» Articles » PMID: 35915684

Significance of C-reactive Protein Levels in Categorizing Upper and Lower Urinary Tract Infection in Adult Patients

Overview
Journal Cureus
Date 2022 Aug 2
PMID 35915684
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Urinary tract infections (UTIs) are one of the most commonly encountered infections in outpatients. The distinction between upper UTI and lower UTI is significant as it has therapeutic and prognostic importance. The accurate diagnosis of UTI, especially its anatomical location, is essential for administering anti-microbial therapy successfully. Plasma levels of C-reactive protein (CRP) increase 1,000-fold during bacterial infections. Elevated CRP levels are often seen in acute pyelonephritis and rarely in cystitis. Therefore, this study aimed to evaluate the diagnostic role of serum CRP in upper and lower UTI in adult patients along with correlating its role in UTI patients.

Materials And Methods: The study included 81 patients who were >18 years old, diagnosed with UTI by microbiological culture and ultrasonography of the pelvis. Demographic data along with findings of the systemic examination, complete blood count, random blood sugar, urine analysis, and CRP levels of all patients were recorded. Data were analyzed using R Studio.3.5.3 software, and a p-value ≤ 0.05 was considered significant.

Results: The prevalence of UTI was higher among females (60.49%). About 53.09% of patients exhibited upper and 46.91% exhibited lower UTI. The prevalence of was higher among cases of both upper (88.37%) and lower (65.79%) UTI. The most common final diagnosis in upper UTI patients was acute pyelonephritis (90.7%) and that in lower UTI was cystitis (65.79%). The difference in the CRP levels between the upper and lower UTI patients was significant (p=0.02). Thirty-four patients had CRP levels >100 mg/L, all exhibiting upper UTI.

Conclusion: About 53.09% of patients exhibited upper UTI and were diagnosed with acute pyelonephritis. A significant increase in the CRP levels in upper UTI can help determine the anatomical location and can help in targeting effective management of the infection by anti-microbial therapy.

Citing Articles

Sustainable nanophytosome-based therapies against multidrug-resistant Escherichia coli in urinary tract infections: an in Vitro and in vivo study.

Wen M, Abdelwahab I, Abozahra R, Abdelhamid S, Baraka K, Ahmed H J Nanobiotechnology. 2025; 23(1):174.

PMID: 40050888 PMC: 11883929. DOI: 10.1186/s12951-024-03006-1.


Acute phase proteins patterns as biomarkers in bacterial infection: Recent insights.

Al Ali A, Darwish W Open Vet J. 2024; 14(10):2539-2550.

PMID: 39545194 PMC: 11560262. DOI: 10.5455/OVJ.2024.v14.i10.4.


Noninvasive, Multimodal Inflammatory Biomarker Discovery for Systemic Inflammation (NOVA Study): Protocol for a Cross-Sectional Study.

Shim J, Muraru S, Dobrota R, Fleisch E, Distler O, Barata F JMIR Res Protoc. 2024; 13:e62877.

PMID: 39499914 PMC: 11576606. DOI: 10.2196/62877.


Comprehensive insights into UTIs: from pathophysiology to precision diagnosis and management.

Sujith S, Solomon A, Rayappan J Front Cell Infect Microbiol. 2024; 14:1402941.

PMID: 39380727 PMC: 11458535. DOI: 10.3389/fcimb.2024.1402941.


Innovative Biosensor Technologies in the Diagnosis of Urinary Tract Infections: A Comprehensive Literature Review.

Celik H, Caf B, Cebi G Indian J Microbiol. 2024; 64(3):894-909.

PMID: 39282176 PMC: 11399381. DOI: 10.1007/s12088-024-01359-7.


References
1.
Mushi M, Alex V, Seugendo M, Silago V, Mshana S . C - reactive protein and urinary tract infection due to Gram-negative bacteria in a pediatric population at a tertiary hospital, Mwanza, Tanzania. Afr Health Sci. 2020; 19(4):3217-3224. PMC: 7040338. DOI: 10.4314/ahs.v19i4.45. View

2.
Leick M, Azcutia V, Newton G, Luscinskas F . Leukocyte recruitment in inflammation: basic concepts and new mechanistic insights based on new models and microscopic imaging technologies. Cell Tissue Res. 2014; 355(3):647-56. PMC: 3994997. DOI: 10.1007/s00441-014-1809-9. View

3.
Sewify M, Nair S, Warsame S, Murad M, Alhubail A, Behbehani K . Prevalence of Urinary Tract Infection and Antimicrobial Susceptibility among Diabetic Patients with Controlled and Uncontrolled Glycemia in Kuwait. J Diabetes Res. 2016; 2016:6573215. PMC: 4710901. DOI: 10.1155/2016/6573215. View

4.
Hellerstein S, Duggan E, Welchert E, Mansour F . Serum C-reactive protein and the site of urinary tract infections. J Pediatr. 1982; 100(1):21-5. DOI: 10.1016/s0022-3476(82)80229-1. View

5.
Gabay C, Kushner I . Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 1999; 340(6):448-54. DOI: 10.1056/NEJM199902113400607. View